Contract Research Services

About Imanis Life Sciences

Imanis Life Sciences is a specialized contract research organization (CRO) and product provider founded in 2015 and headquartered in Rochester, Minnesota. The company operates at the intersection of virology, cell engineering, and immuno-oncology, offering custom services and products to accelerate therapeutic development for biopharma clients. Its core capabilities include generating engineered cell lines (e.g., luciferase, iRFP, GFP), developing lentiviral and AAV vectors, and providing assay development and preclinical study services for oncolytic viruses, cell/gene therapies, and vaccines. While it has commercialized diagnostic tests for COVID-19, its primary business model is service- and product-based support for the research and development pipeline of other companies.

About FFA Sciences

FFA Sciences has developed a proprietary, patented platform based on fluorescently labeled fatty acid-binding proteins (FABPs), such as ADIFAB and ADIFAB2, to measure unbound free fatty acids in biological fluids in under a minute. While its initial focus is on ophthalmology, where FFAu is implicated in diseases like diabetic retinopathy and dry AMD, the technology has broad applicability in drug discovery, enzymology, and metabolomics profiling. The company generates revenue through the sale of assay kits and reagents, as well as providing contract research services, positioning it as a tools and services company rather than a therapeutic developer.

About Xona Microfluidics

Xona Microfluidics is a specialized tools and services company at the intersection of microengineering and neuroscience. It commercializes the seminal 'XonaChip' platform, which enables the precise compartmentalization of neuronal cultures for studying subcellular processes, axon biology, and disease models. Beyond product sales, the company has leveraged its scientific expertise to build a contract research organization (CRO) arm and consistently secures NIH grant funding for R&D. Positioned in the Research Triangle Park ecosystem, Xona serves academic, biotech, and pharmaceutical researchers aiming to de-risk neurological drug discovery.

Therapeutic Areas